These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
177 related articles for article (PubMed ID: 18622204)
21. Is the metabolic syndrome an intracellular Cushing state? Effects of multiple humoral factors on the transcriptional activity of the hepatic glucocorticoid-activating enzyme (11beta-hydroxysteroid dehydrogenase type 1) gene. Iwasaki Y; Takayasu S; Nishiyama M; Tsugita M; Taguchi T; Asai M; Yoshida M; Kambayashi M; Hashimoto K Mol Cell Endocrinol; 2008 Mar; 285(1-2):10-8. PubMed ID: 18313835 [TBL] [Abstract][Full Text] [Related]
22. H6PDH interacts directly with 11beta-HSD1: implications for determining the directionality of glucocorticoid catalysis. Zhang YL; Zhong X; Gjoka Z; Li Y; Stochaj W; Stahl M; Kriz R; Tobin JF; Erbe D; Suri V Arch Biochem Biophys; 2009 Mar; 483(1):45-54. PubMed ID: 19121282 [TBL] [Abstract][Full Text] [Related]
23. Steroid biomarkers and genetic studies reveal inactivating mutations in hexose-6-phosphate dehydrogenase in patients with cortisone reductase deficiency. Lavery GG; Walker EA; Tiganescu A; Ride JP; Shackleton CH; Tomlinson JW; Connell JM; Ray DW; Biason-Lauber A; Malunowicz EM; Arlt W; Stewart PM J Clin Endocrinol Metab; 2008 Oct; 93(10):3827-32. PubMed ID: 18628520 [TBL] [Abstract][Full Text] [Related]
24. 11Beta-hydroxysteroid dehydrogenase enzymes in the testis and male reproductive tract of the boar (Sus scrofa domestica) indicate local roles for glucocorticoids in male reproductive physiology. Sharp V; Thurston LM; Fowkes RC; Michael AE Reproduction; 2007 Sep; 134(3):473-82. PubMed ID: 17709565 [TBL] [Abstract][Full Text] [Related]
26. Minireview: hexose-6-phosphate dehydrogenase and redox control of 11{beta}-hydroxysteroid dehydrogenase type 1 activity. Hewitt KN; Walker EA; Stewart PM Endocrinology; 2005 Jun; 146(6):2539-43. PubMed ID: 15774558 [TBL] [Abstract][Full Text] [Related]
27. Maintenance of luminal NADPH in the endoplasmic reticulum promotes the survival of human neutrophil granulocytes. Kardon T; Senesi S; Marcolongo P; Legeza B; Bánhegyi G; Mandl J; Fulceri R; Benedetti A FEBS Lett; 2008 Jun; 582(13):1809-15. PubMed ID: 18472006 [TBL] [Abstract][Full Text] [Related]
28. Cooperativity between 11beta-hydroxysteroid dehydrogenase type 1 and hexose-6-phosphate dehydrogenase in the lumen of the endoplasmic reticulum. Bánhegyi G; Benedetti A; Fulceri R; Senesi S J Biol Chem; 2004 Jun; 279(26):27017-21. PubMed ID: 15090536 [TBL] [Abstract][Full Text] [Related]
30. Inhibition of microsomal cortisol production by (-)-epigallocatechin-3-gallate through a redox shift in the endoplasmic reticulum--a potential new target for treating obesity-related diseases. Szelényi P; Révész K; Konta L; Tüttõ A; Mandl J; Kereszturi É; Csala M Biofactors; 2013; 39(5):534-41. PubMed ID: 23554216 [TBL] [Abstract][Full Text] [Related]
31. Glucocorticoid-mediated effects on metabolism are reversed by targeting 11 beta hydroxysteroid dehydrogenase type 1 in human skeletal muscle. Salehzadeh F; Al-Khalili L; Kulkarni SS; Wang M; Lönnqvist F; Krook A Diabetes Metab Res Rev; 2009 Mar; 25(3):250-8. PubMed ID: 19222059 [TBL] [Abstract][Full Text] [Related]
32. 11beta-Hydroxysteroid dehydrogenase 1 reductase activity is dependent on a high ratio of NADPH/NADP(+) and is stimulated by extracellular glucose. Dzyakanchuk AA; Balázs Z; Nashev LG; Amrein KE; Odermatt A Mol Cell Endocrinol; 2009 Mar; 301(1-2):137-41. PubMed ID: 18778749 [TBL] [Abstract][Full Text] [Related]
33. Hexose-6-phosphate dehydrogenase modulates the effect of inhibitors and alternative substrates of 11beta-hydroxysteroid dehydrogenase 1. Balázs Z; Nashev LG; Chandsawangbhuwana C; Baker ME; Odermatt A Mol Cell Endocrinol; 2009 Mar; 301(1-2):117-22. PubMed ID: 19010388 [TBL] [Abstract][Full Text] [Related]
34. Abnormalities of glucose homeostasis and the hypothalamic-pituitary-adrenal axis in mice lacking hexose-6-phosphate dehydrogenase. Rogoff D; Ryder JW; Black K; Yan Z; Burgess SC; McMillan DR; White PC Endocrinology; 2007 Oct; 148(10):5072-80. PubMed ID: 17656460 [TBL] [Abstract][Full Text] [Related]
35. [Glucocorticoids, 11 beta-hydroxysteroid dehydrogenase type 1, and visceral obesity]. Paulmyer-Lacroix O; Boullu-Ciocca S; Oliver C; Dutour A; Grino M Med Sci (Paris); 2003 Apr; 19(4):473-6. PubMed ID: 12836221 [TBL] [Abstract][Full Text] [Related]
37. 11beta-hydroxysteroid dehydrogenase 2 activity is elevated in severe obesity and negatively associated with insulin sensitivity. Müssig K; Remer T; Haupt A; Gallwitz B; Fritsche A; Häring HU; Maser-Gluth C Obesity (Silver Spring); 2008 Jun; 16(6):1256-60. PubMed ID: 18421276 [TBL] [Abstract][Full Text] [Related]
38. Lack of Association of the 11beta-hydroxysteroid dehydrogenase type 1 gene 83,557insA and hexose-6-phosphate dehydrogenase gene R453Q polymorphisms with body composition, adrenal androgen production, blood pressure, glucose metabolism, and dementia. Smit P; Dekker MJ; de Jong FJ; van den Beld AW; Koper JW; Pols HA; Brinkmann AO; de Jong FH; Breteler MM; Lamberts SW J Clin Endocrinol Metab; 2007 Jan; 92(1):359-62. PubMed ID: 17062770 [TBL] [Abstract][Full Text] [Related]
39. [11 beta-Hydroxysteroid dehydrogenase]. Sun G; Li P; Yang KP; Challis JR Sheng Li Ke Xue Jin Zhan; 1998 Oct; 29(4):301-6. PubMed ID: 12501657 [TBL] [Abstract][Full Text] [Related]
40. Metyrapone prevents cortisone-induced preadipocyte differentiation by depleting luminal NADPH of the endoplasmic reticulum. Marcolongo P; Senesi S; Gava B; Fulceri R; Sorrentino V; Margittai E; Lizák B; Csala M; Bánhegyi G; Benedetti A Biochem Pharmacol; 2008 Aug; 76(3):382-90. PubMed ID: 18599022 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]